Guided bone regeneration in osteoporotic conditions following treatment with zoledronic acid.

about

Poly(Vinylidene Fluoride-Trifluorethylene)/barium titanate membrane promotes de novo bone formation and may modulate gene expression in osteoporotic rat model.

P2860

Q48283302-51C8A76A-7C73-41BE-B250-ABE4CA761553

P2860

Guided bone regeneration in osteoporotic conditions following treatment with zoledronic acid.

Item

http://www.wikidata.org/entity/Q50926376

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Guided bone regeneration in os ...... reatment with zoledronic acid.

@en

Guided bone regeneration in os ...... reatment with zoledronic acid.

@nl

type

Item

label

Guided bone regeneration in os ...... reatment with zoledronic acid.

@en

Guided bone regeneration in os ...... reatment with zoledronic acid.

@nl

prefLabel

Guided bone regeneration in os ...... reatment with zoledronic acid.

@en

Guided bone regeneration in os ...... reatment with zoledronic acid.

@nl

P1476

Guided bone regeneration in os ...... reatment with zoledronic acid.

@en

P2093

José Antonio Poli de Figueiredo

http://www.w3.org/2001/XMLSchema#string

Juliano Busetti

http://www.w3.org/2001/XMLSchema#string

Luis André Mezzomo

http://www.w3.org/2001/XMLSchema#string

Nikolaos Donos

http://www.w3.org/2001/XMLSchema#string

Nikos Mardas

http://www.w3.org/2001/XMLSchema#string

Roberta Kochenborger Scarparo

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.

Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats.

Osteoporosis influences the early period of fracture healing in a rat osteoporotic model.

Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials.

Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.

Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis.

Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review.

The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors

High-density polytetrafluoroethylene membranes in guided bone and tissue regeneration procedures: a literature review.

Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program.

P304

362-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CLR.12810

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296193655

http://www.w3.org/2001/XMLSchema#string

P698

26920844

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

Guided bone regeneration in osteoporotic conditions following treatment with zoledronic acid.

about

P2860

P2860

Guided bone regeneration in osteoporotic conditions following treatment with zoledronic acid.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921